73 related articles for article (PubMed ID: 19942956)
21. Liquid-based cytology for cervical cancer screening.
Bentz JS
Expert Rev Mol Diagn; 2005 Nov; 5(6):857-71. PubMed ID: 16255628
[TBL] [Abstract][Full Text] [Related]
22. Outcomes in cervical screening using various cytology technologies: what's age got to do with it?
Barken SS; Rebolj M; Lynge E; Junge J; Rygaard C
Eur J Cancer Prev; 2013 Jul; 22(4):367-73. PubMed ID: 22976387
[TBL] [Abstract][Full Text] [Related]
23. Cervicovaginal cytology in uterine adenocarcinoma and adenosquamous carcinoma. Comparison of cytologic and histologic findings.
Costa MJ; Kenny MB; Naib ZM
Acta Cytol; 1991; 35(1):127-34. PubMed ID: 1994621
[TBL] [Abstract][Full Text] [Related]
24. Organisation of cervical cytology screening in Croatia: past, present and future.
Pajtler M; Audy-Jurković S; Kardum-Skelin I; Mahovlić V; Mozetic-Vrdoljak D; Ovanin-Rakić A
Coll Antropol; 2007 Apr; 31 Suppl 2():47-54. PubMed ID: 17598505
[TBL] [Abstract][Full Text] [Related]
25. Repeating cytological preparations on liquid-based cytology samples: A methodological advantage?
Pinto AP; Maia HF; di Loretto C; Krunn P; Túlio S; Collaço LM
Diagn Cytopathol; 2007 Oct; 35(10):663-9. PubMed ID: 17854084
[TBL] [Abstract][Full Text] [Related]
26. A Groundbreaking Work Which Laid the Foundation for Mass Screening in Cervical Cytology in Japan.
Osamura RY
Acta Cytol; 2017; 61(4-5):299-304. PubMed ID: 28693014
[TBL] [Abstract][Full Text] [Related]
27. Comparative study of the results from conventional cervico-vaginal oncotic cytology and liquid-based cytology.
Stabile SA; Evangelista DH; Talamonte VH; Lippi UG; Lopes RG
Einstein (Sao Paulo); 2012; 10(4):466-72. PubMed ID: 23386088
[TBL] [Abstract][Full Text] [Related]
28. Prevalence of Abnormal Cervical Cytology in HIVNegative Women Participating in a Cervical Cancer Screening Program in Calmette Hospital, Cambodia.
Hav M; Eav S; Heang N; Pich P; Lim D; Leang V; Korn A; Lay S; Pluot M; Kruy L
Asian Pac J Cancer Prev; 2016; 17(7):3101-3. PubMed ID: 27509936
[TBL] [Abstract][Full Text] [Related]
29. Evolution in cervical pathology and cytology: a historical perspective.
Koss LG
Eur J Gynaecol Oncol; 2000; 21(6):550-4. PubMed ID: 11214608
[No Abstract] [Full Text] [Related]
30. The Bethesda System for Reporting Cervical Cytology: A Historical Perspective.
Nayar R; Wilbur DC
Acta Cytol; 2017; 61(4-5):359-372. PubMed ID: 28693017
[TBL] [Abstract][Full Text] [Related]
31. Anticipating the impact of the new screening guidelines on cytology and molecular laboratories.
Booth CN
Cancer Cytopathol; 2013 May; 121(5):225-7. PubMed ID: 23281254
[No Abstract] [Full Text] [Related]
32. Diagnostic cytology of the uterine cervix: a major contribution and classic reference in gynecologic cytopathology.
Bonfiglio TA
Cancer; 1997 Dec; 81(6):324-7. PubMed ID: 9438455
[No Abstract] [Full Text] [Related]
33. Different strokes: Pap-test and Babes method are not one and the same.
Diamantis A; Magiorkinis E; Androutsos G
Diagn Cytopathol; 2010 Nov; 38(11):857-9. PubMed ID: 20973044
[No Abstract] [Full Text] [Related]
34. Concurrent discoveries of the value of vaginal smears for diagnosis of uterine cancer.
Koprowska I
Diagn Cytopathol; 1985; 1(3):245-8. PubMed ID: 3915249
[TBL] [Abstract][Full Text] [Related]
35. Aurel Babeş.
Koss LG
Int J Gynecol Pathol; 2003 Jan; 22(1):101-2. PubMed ID: 12496707
[No Abstract] [Full Text] [Related]
36. XII. Aurel Babeş.
Tasca L; Ostör AG; Babeş V
Int J Gynecol Pathol; 2002 Apr; 21(2):198-202. PubMed ID: 11917233
[No Abstract] [Full Text] [Related]
37. What's in a name? Evidence that Papanicolaou, not Babes, deserves credit for the Pap test.
Diamantis A; Magiorkinis E; Androutsos G
Diagn Cytopathol; 2010 Jul; 38(7):473-6. PubMed ID: 19813255
[TBL] [Abstract][Full Text] [Related]
38. Contested surveillance: risk, safety, and cervical screening in Australia.
Read J; Hardy S; Corones A
Health History; 2011; 13(2):104-29. PubMed ID: 22329262
[TBL] [Abstract][Full Text] [Related]
39. [The beginning of gynecologic cytology for cancer diagnosis in Germany].
Blohmer JU; Lau HU
Zentralbl Gynakol; 1994; 116(6):365-7. PubMed ID: 8048294
[TBL] [Abstract][Full Text] [Related]
40. Utility of histiocytic immunomarkers in differentiating histiocytic aggregates with marked nuclear atypia from high grade squamous intraepithelial lesions in liquid-based cervicovaginal cytology specimens.
Giorgadze T; Miller LE; Preiszner J; Nassar A
Acta Cytol; 2009; 53(4):479-81. PubMed ID: 19697743
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
